首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis of hydrolysis-resistant pyridoxal 5 '-phosphate analogs and their biochemical and X-ray crystallographic characterization with the pyridoxal phosphatase chronophin
【24h】

Synthesis of hydrolysis-resistant pyridoxal 5 '-phosphate analogs and their biochemical and X-ray crystallographic characterization with the pyridoxal phosphatase chronophin

机译:抗水解吡ido醛5'-磷酸盐类似物的合成及其吡chemical醛磷酸酶历时蛋白的生化和X射线晶体学表征

获取原文
获取原文并翻译 | 示例
           

摘要

A set of phosphonic acid derivatives (1-4) of pyridoxal 5'-phosphate (PLP) was synthesized and characterized biochemically using purified murine pyridoxal phosphatase (PDXP), also known as chronophin. The most promising compound 1 displayed primarily competitive PDXP inhibitory activity with an IC50 value of 79 mu M, which was in the range of the K-m of the physiological substrate PLP. We also report the X-ray crystal structure of PDXP bound to compound 3, which we solved to 2.75 angstrom resolution (PDB code 5AES). The co-crystal structure proves that compound 3 binds in the same orientation as PLP, and confirms the mode of inhibition to be competitive. Thus, we identify compound 1 as a PDXP phosphatase inhibitor. Our results suggest a strategy to design new, potent and selective PDXP inhibitors, which may be useful to increase the sensitivity of tumor cells to treatment with cytotoxic agents. (C) 2015 Elsevier Ltd. All rights reserved.
机译:合成了一组吡ido醛5'-磷酸(PLP)的膦酸衍生物(1-4),并使用纯化的鼠类吡ido醛磷酸酶(PDXP)(也称为chronophin)进行生物化学表征。最有前途的化合物1主要表现出竞争性PDXP抑制活性,IC50值为79μM,在生理底物PLP的K-m范围内。我们还报告了与化合物3结合的PDXP的X射线晶体结构,我们将其解析为2.75埃分辨率(PDB代码5AES)。共晶体结构证明化合物3以与PLP相同的方向结合,并确认抑制方式具有竞争性。因此,我们确定化合物1为PDXP磷酸酶抑制剂。我们的结果提出了设计新的,有效的和选择性的PDXP抑制剂的策略,这可能有助于提高肿瘤细胞对细胞毒素治疗的敏感性。 (C)2015 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号